DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,071 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,222 | +7.3% | 8,893 | +7.2% | 0.06% | 0.0% |
Q1 2024 | $2,071 | +8.0% | 8,292 | +0.0% | 0.06% | -6.0% |
Q4 2023 | $1,917 | -2.6% | 8,288 | +4.4% | 0.07% | -6.9% |
Q3 2023 | $1,969 | +119.8% | 7,938 | +112.6% | 0.07% | +140.0% |
Q2 2023 | $896 | -3.2% | 3,734 | +1.6% | 0.03% | -9.1% |
Q1 2023 | $926 | -4.9% | 3,675 | +0.1% | 0.03% | -10.8% |
Q4 2022 | $974 | -99.9% | 3,671 | +0.1% | 0.04% | -7.5% |
Q3 2022 | $947,000 | +1.9% | 3,668 | +0.1% | 0.04% | +5.3% |
Q2 2022 | $929,000 | -13.5% | 3,664 | +0.1% | 0.04% | +11.8% |
Q1 2022 | $1,074,000 | -10.8% | 3,661 | +0.1% | 0.03% | -12.8% |
Q4 2021 | $1,204,000 | +8.2% | 3,658 | +0.1% | 0.04% | +8.3% |
Q3 2021 | $1,113,000 | +13.6% | 3,656 | +0.1% | 0.04% | +16.1% |
Q2 2021 | $980,000 | +19.2% | 3,653 | +0.1% | 0.03% | +6.9% |
Q1 2021 | $822,000 | +1.4% | 3,650 | 0.0% | 0.03% | -3.3% |
Q4 2020 | $811,000 | +3.2% | 3,650 | 0.0% | 0.03% | +7.1% |
Q3 2020 | $786,000 | +21.9% | 3,650 | 0.0% | 0.03% | +12.0% |
Q2 2020 | $645,000 | – | 3,650 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |